Latest Stock Buy or Sell? Make More Informed Decisions!

It reports Tuesday. The weight-loss drugs make it hard for PEP to thrive. It pays a 3.6% dividend, though.

It reports Tuesday. Is their search business cannabilized by Gemini AI? YouTube is on fire and covers up weakness. Listen for any growth in their infrastructure business--if strong, shares will fly.

It reports Tuesday. In the wake of DeepSeek, AMD's cheaper than NVDA's GPU suddenly looked more attractive thatn NVDA's chips.

It reports Tuesday. Always buy on dips. Is a fine growth stock in restaurants. 

It reports Wednesday. Hurricanes impacted last quarter and the LA wildfires could impact the forecast in this quarter. But all else is hitting on all cyclinders incuding linear TV. Could be putting recent weakness behind them, and shares are historically cheap.

It reports Wednesday. Eli Lilly has already announced soft Q4 sales, but expects a good 2025, so how is NVO doing? Maybe buy some shares before the report.

It reports Wednesday. It has disappointed due to warranty costs. With long-term interest costs high and likely rising, their sales could be stalling. The stock has been awful.

It reports Thursday. He needs to hear more details before stepping in

It reports Thursday. Watch for news on Cobenfy, the new schizophrenia drug in 30 years, and potentially good. And with their yield, BMY is one of his favourites.

It report Thursday. He expects terrific numbers, but they may not need to be that terrific to justify its recent rally. Maybe wait till after the quarter.

It just reported great numbers and shares jumped 13%. Redhat has made this an AI winner. It rallied 34% last year. They've had 6 straight quarters of positive sales growth, leading to an earnings beat and excellent free cash flow. Their full year forecast includes accelerating revenue growth and free cash flow. YOY growth: infrastructure -8%, consulting -2%, software 10% which is the largest segment, amounting to 43% of 2024 revenues. Software got stronger as 2024 wore on, and this segment could make up 50% of IBM's business. Specifically, Red Hat grew 16% YOY in Q4 and automation 15%. Watson X and Red Hat are key growers, enjoying the AI tailwind. Their GenAI business generates over $5 billion of business, growing by $2 billion, quarter-over-quarter. That said, shares went sideways last October given a miss in their consulting business, but the CEO feels AI will return this segment to growth in 2026. Tailwinds: a good backlog, record signing in Q4, and business in GenAI all support accelerating growth in low-single digits. Caveat: their PE is 24x PE and 22x in 2026, instead of around 10x, but their return to steady growth justifies the PE and software will generate more recurring revenue. An indirect AI play that won't be hurt by DeepSeek.

Has doubled since last June's lows, but weirdly without a fundamental change in its business, like a beat and raise quarter, just some raised guidance. The CEO did buy a lot of shares last June.

It has seen strong insider buying, and a strong quarter with the slower cyclical segments finally turning the corner.

Down 75% from its high, not an opportunity, because accounting irregularities always mean sell.

It just reported a slight miss and a light forecast, but shares fell a little because of its steady track record.